Keyphrases
Clinically Significant
100%
Glioma
100%
Molecular Pathways
100%
Central Nervous System Tumors
100%
Tumor
66%
Enzymatic Activity
66%
Clinical Trials
33%
Tumor Cells
33%
Quality of Life
33%
Cancer-related
33%
Therapeutic Agents
33%
Signaling Pathway
33%
Molecular Biology
33%
Novel Therapeutics
33%
Patient Outcomes
33%
Dismal Prognosis
33%
Glioma Patients
33%
Median Survival
33%
Tumor Subtype
33%
Poor Prognosis
33%
Human Cancer
33%
Primary Brain Tumor
33%
Glial Cells
33%
Platelet-derived Growth Factor Receptor (PDGFR)
33%
Negatively Regulate
33%
Small Fraction
33%
Epidermal Growth Factor Receptor
33%
Genetic Pathways
33%
Pro-tumorigenic
33%
Cytostatic
33%
Therapeutic Relevance
33%
Pathway Alteration
33%
Glial Tumors
33%
Oligodendroglioma
33%
Diagnostic Significance
33%
Growth Factor Receptor Signaling
33%
Signaling Effectors
33%
High-grade Astrocytoma
33%
Low-grade Astrocytoma
33%
Specific Enzymatic Activity
33%
PTEN Tumor Suppressor Gene
33%
Medicine and Dentistry
Ganglioglioma
100%
Central Nervous System Tumor
75%
Enzyme Activity
75%
Neoplasm
50%
Therapeutic Agent
50%
Malignant Neoplasm
50%
Oligoastrocytoma
50%
Intracranial Tumor
25%
Diagnosis
25%
Tumor Cell
25%
Tumor Suppressor Gene
25%
Epidermal Growth Factor Receptor
25%
Protein P53
25%
Platelet Derived Growth Factor Receptor
25%
P16
25%
Cytostatic Agent
25%
Oligodendroglioma
25%
Clinical Trial
25%
Quality of Life
25%
Signal Transduction
25%
Microglia
25%
Pharmacology, Toxicology and Pharmaceutical Science
Central Nervous System Tumor
100%
Neoplasm
100%
Malignant Neoplasm
66%
Astrocytoma
66%
Clinical Trial
33%
Glioma
33%
Protein P53
33%
Tumor Suppressor Protein
33%
Intracranial Tumor
33%
Platelet Derived Growth Factor Receptor
33%
Cytostatic Agent
33%
Epidermal Growth Factor Receptor
33%
Oligodendroglioma
33%
Neuroscience
Central Nervous System
100%
Enzyme Activity
100%
Astrocytoma
66%
Cell Signaling
33%
P53
33%
Oligodendroglioma
33%
Tumor Suppressor Gene
33%
Platelet-Derived Growth Factor Receptor
33%
Microglia
33%
Epidermal Growth Factor Receptor
33%
Intracranial Tumor
33%
Biochemistry, Genetics and Molecular Biology
Enzyme Activity
100%
Signal Transduction
33%
Clinical Trial
33%
Genetics
33%
Molecular Biology
33%
Glial Cells
33%
Tumor Suppressor Gene
33%
P16
33%
Microglia
33%
P53
33%
Epidermal Growth Factor Receptor
33%
Platelet-Derived Growth Factor Receptor
33%